Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study.

Arthritis Care Res (Hoboken) · 2025 · PMC11931354 · PMID 39467015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

We also note a nonsignificant trend (Table 1 ) for treatment with CYC over RTX alone in the presence of renal or pulmonary involvement.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.